The document discusses an exchange between Dr. Mark Babizhayev and the editor of Macromolecular Bioscience regarding a submission by Dr. Babizhayev. The editor rejects the submission, stating that it falls outside the journal's scope. Dr. Babizhayev then provides details on his lineage as a descendant of Wallis Simpson and claims unofficial status as King of the UK. He pressures the editor to publish the rejected article by threatening negative publicity, noting their Twitter account and potential removal from the public domain. The editor maintains the decision not to consider the article further.
Keep up-to-date with the latest news from Haag-Streit UK and John Weiss by checking out our latest 'In Focus' newsletter. The newsletter contains all the most recent updates from both organisations, from product launches to events to special offers.
An issue of argue with "Progress in Biophysics and Molecular Biology" (the Jo...Mark Babizhayev
An Issue of Argue with "Progress in Biophysics and Molecular Biology"(the Journal of Elsevier Publisher), Xin Ni, Ph.D Special Issue Guest Editor Progress in Biophysics and Molecular Biology
(based at the e-mail address: <ees.pbmb.0.3b6393.ec55f389@eesmail.elsevier.com>)
Case study of Gary Walker a former NHS CEO and whistleblower. Contains extracts of documents that describe the the pursuit of targets that led to a cover up costing over £500k involving the most senior people in the NHS. Shared at a presentation for BSI on 2 July 2014
21 top health and safety twitter handles you should followUBONG EDET
In this article, I will mention top health and safety twitter handles you should follow as a health and safety professional.
The list will be made up of top players in the Health and safety profession. Following them will link you up with current trends and innovations in the Health and safety profession.
Babizhayev MA (2017) Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a
Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and
Disease. Qual Prim Health Care (2017) 1:1 001
Babizhayev MA (2017) Treatment of Skin Aging and Photoaging with Innovative O...Mark Babizhayev
Babizhayev MA (2017) Treatment of Skin Aging and Photoaging with Innovative Oral Dosage Forms of Non-Hydrolized Carnosine and Carcinine. Int J Clin Dermatol Res. 5(5), 116-143.
Babizhayev MA: Drug Design of Mitochondria-Targeted Antioxidants, Action, Met...Mark Babizhayev
Babizhayev MA Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for
Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform International Journal of Ophthalmology & Eye Science
Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and DiseaseMark A Babizhayev*Innovative Vision Products, County of New Castle, Delaware, USAReceived March 19, 2017; Accepted April 26, 2017; Published May 03, 2017*Corresponding author: Dr. Mark A Babizhayev, Innovative Vision Products, Inc., Moscow Division, Ivanovskaya 20, Suite 74 Moscow 127434 Russian Federation, County of New Castle, Delaware, USA; Tel: +7(499) 977-2387; E-mail: markbabizhayev@mail.ru Citation: Babizhayev MA (2017) Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and Disease. Qual Prim Health Care (2017) 1:1 001
Dr. Mark A. Babizhayev Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for
Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform - Int J Ophthalmol Eye Res. 2017 5(4), 287-307.
Keep up-to-date with the latest news from Haag-Streit UK and John Weiss by checking out our latest 'In Focus' newsletter. The newsletter contains all the most recent updates from both organisations, from product launches to events to special offers.
An issue of argue with "Progress in Biophysics and Molecular Biology" (the Jo...Mark Babizhayev
An Issue of Argue with "Progress in Biophysics and Molecular Biology"(the Journal of Elsevier Publisher), Xin Ni, Ph.D Special Issue Guest Editor Progress in Biophysics and Molecular Biology
(based at the e-mail address: <ees.pbmb.0.3b6393.ec55f389@eesmail.elsevier.com>)
Case study of Gary Walker a former NHS CEO and whistleblower. Contains extracts of documents that describe the the pursuit of targets that led to a cover up costing over £500k involving the most senior people in the NHS. Shared at a presentation for BSI on 2 July 2014
21 top health and safety twitter handles you should followUBONG EDET
In this article, I will mention top health and safety twitter handles you should follow as a health and safety professional.
The list will be made up of top players in the Health and safety profession. Following them will link you up with current trends and innovations in the Health and safety profession.
Babizhayev MA (2017) Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a
Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and
Disease. Qual Prim Health Care (2017) 1:1 001
Babizhayev MA (2017) Treatment of Skin Aging and Photoaging with Innovative O...Mark Babizhayev
Babizhayev MA (2017) Treatment of Skin Aging and Photoaging with Innovative Oral Dosage Forms of Non-Hydrolized Carnosine and Carcinine. Int J Clin Dermatol Res. 5(5), 116-143.
Babizhayev MA: Drug Design of Mitochondria-Targeted Antioxidants, Action, Met...Mark Babizhayev
Babizhayev MA Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for
Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform International Journal of Ophthalmology & Eye Science
Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and DiseaseMark A Babizhayev*Innovative Vision Products, County of New Castle, Delaware, USAReceived March 19, 2017; Accepted April 26, 2017; Published May 03, 2017*Corresponding author: Dr. Mark A Babizhayev, Innovative Vision Products, Inc., Moscow Division, Ivanovskaya 20, Suite 74 Moscow 127434 Russian Federation, County of New Castle, Delaware, USA; Tel: +7(499) 977-2387; E-mail: markbabizhayev@mail.ru Citation: Babizhayev MA (2017) Advanced Glycation End Products: Free Radical Generation by Early Glycation Products as a Mechanism for Long-Term Complications of Diabetes Mellitus: Toxicity, Regulation, Function and Role in Health, Nutrition and Disease. Qual Prim Health Care (2017) 1:1 001
Dr. Mark A. Babizhayev Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for
Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform - Int J Ophthalmol Eye Res. 2017 5(4), 287-307.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
An issue of argue with “Macromolecular Bioscience”
1. 1
An Issue of Argue with “Macromolecular Bioscience”
(mabi.201600354) - [EMID:ede5826a460a4a62]
Dr. David Huesmann, Editor
Macromolecular Bioscience
Email: macromol@wiley-vch.de
Phone: +49 6201-606-581
http://mbs-journal.de/
=========================
Editorial Office, Macromolecular Journals
Wiley-VCH Verlag GmbH & Co. KGaA
Boschstrasse 12, 69469 Weinheim, Germany
Email: macromol@wiley-vch.de
Phone: +49 6201-606-581
Fax: +49 6201-606-510
Homepages & Full Text: http://www.macros.wiley-vch.de
Best of Macromolecular Journals: http://best-of-macros.de (Free
Access!)
----------
*****
Wiley-VCH Verlag GmbH & Co. KGaA – A company of John
Wiley & Sons, Inc. - Location of the Company: Weinheim -
Trade Register: Mannheim, HRB 432833.
Chairman of the Supervisory Board: Mark Allin. General
Partner: John Wiley & Sons GmbH, Location: Weinheim –
Trade Register Mannheim, HRB 432296 – Managing Directors:
Sabine Steinbach, Philip Carpenter
*****
Dear Editor,
Kindly be a little bit explicit for the due diligence process :
Are you saying that : Advanced Glycation End Products have nothing in
common with the Macromolecular Bioscience ?
We are looking forward to hearing from you again.
2. 2
Thank you.
Cordially, Dr. Mark A. Babizhayev
--------------------------------------------
On Fri, 8/19/16, MACRO <macromol@wiley-vch.de> wrote:
Subject: AW: Your submission to Macromolecular Bioscience
(mabi.201600354) - [EMID:ede5826a460a4a62]
To: "Innovative Vision Products, Inc. Mark A. Babizhayev"
<markbabizhayev2005@yahoo.com>
Date: Friday, August 19, 2016, 1:33 PM
Dear Dr. Babizhayev,
your article falls outside of the scope of Macromolecular Bioscience and
will therefore not be considered further.
With kind regards,
David Huesmann
=========================
Editorial Office, Macromolecular Journals
Wiley-VCH Verlag GmbH & Co. KGaA
Boschstrasse 12, 69469 Weinheim, Germany
Email: macromol@wiley-vch.de
Phone: +49 6201-606-581
Fax: +49 6201-606-510
Homepages & Full Text: http://www.macros.wiley-vch.de
Best of Macromolecular Journals: http://best-of-macros.de (Free
Access!)
----------
MCP Special Issue "Young Talents in Polymer Science, Parts 1 & 2"
guest-edited by Laura Hartmann, Bin Liu, Bradley D. Olsen
http://doi.wiley.com/10.1002/macp.v217.2
3. 3
http://doi.wiley.com/10.1002/macp.v217.3
MRC Special Issue "Advanced Functional Polymers Addressing the
Needs of Modern Medicine"
guest-edited by Andreas Lendlein and Abhay Pandit
http://doi.wiley.com/10.1002/marc.v36.21
MRE Special Issue "Product Design of Hybrids"
guest-edited by María Paulis, José M. Asua
http://doi.wiley.com/10.1002/mren.v10.1
----------
Bringing you tomorrow's materials science:
http://MaterialsViews.com and http://MaterialsViewsChina.com
----------
________________________________________
Von: Innovative Vision Products, Inc. Mark A. Babizhayev
<markbabizhayev2005@yahoo.com>
Gesendet: Donnerstag, 18. August 2016 14:59
An: Mark Babizhayev; MACRO
Betreff: Your submission to Macromolecular Bioscience
(mabi.201600354) - [EMID:ede5826a460a4a62]
Dear Editor ,
Dear Dr. David Huesmann,
Thank you for the provided comments which we feel to perceive as the
very formal declaration.
Recently, the certain appeals have been made to the President of the
USA, Japanese Prime Minister Abe, HM British Queen Elizabeth II
about the Genealogical studies inherent to Dr. Mark Babizhayev and the
Members of his Family .
The inheritance has been unequivocally proved with the number of
4. 4
relevant modern and classical approaches.
Dr. Mark Babizhayev is the Senior Great Grandson of Wallis
Simpson (Bessie Wallis Warfield-Spencer-Simpson) USA wife of
Edward VIII & King of UK Edward VIII “David” (Edward Albert
Christian George Andrew Patrick David) Prince of Wales UK, Duke
& Duchess of Windsor .
In other words, Dr. Mark Babizhayev has an "Unofficial Status of a
King of UK" and is the Major relative of the British Royal Family.
Here are below the Illustration Photos :
The Upper Image :
The Image of the King George V. George V (George Frederick
Ernest Albert; 3 June 1865 – 20 January 1936) was King of the
United Kingdom and the British Dominions, and Emperor of India,
from 6 May 1910 until his death in 1936.
He was the second son of Albert Edward, Prince of Wales (later
King Edward VII), and the grandson of the reigning British
monarch, Queen Victoria.
5. 5
The Lower Image:
Dr. Mark Babizhayev in Monte Carlo (An Individual placed in the
centre of the Image), Principauté De Monaco
6. 6
***
The Next pair of the Guiding Photos :
The Upper Image:
Dr. Mark A. Babizhayev in Germany (Bonn)
The Lower image
Edward VII (Albert Edward; 9 November 1841 – 6 May 1910) was
King of the United Kingdom and the British Dominions and
Emperor of India from 22 January 1901 until his death in 1910.
The eldest son of Queen Victoria and Prince Albert of Saxe-Coburg
and Gotha, Edward was related to royalty throughout Europe.
Before his accession to the throne, he served as heir apparent and
held the title of Prince of Wales for longer than any of his
predecessors.
8. 8
Here are below the third pair of the Illustration Photos :
The Upper image
Edward VII (Albert Edward; 9 November 1841 – 6 May 1910) was
King of the United Kingdom and the British Dominions and
Emperor of India from 22 January 1901 until his death in 1910.
The eldest son of Queen Victoria and Prince Albert of Saxe-Coburg
and Gotha, Edward was related to royalty throughout Europe.
Before his accession to the throne, he served as heir apparent and
held the title of Prince of Wales for longer than any of his
predecessors.
10. 10
The phenotypic resemblance of Dr. Mark Babizhayev to the main Kings
of the UK is obvious for Everybody…
The detailed data are described shortly on The Twitter :
Albert II Grimaldi@markinmonaco .
https://twitter.com/markinmonaco/with_replies
We invite you to publish our work in your scientific vehicle/Journal
as it is, in view of the above Official assumption, regardless the
Subjective opinions of your Staff/yours provided below.
Please, make the following note upon the Publication of the Materials
making the asterisk symbol and disclosure following the title of the
Article :
Dr. Mark Babizhayev is the Senior Great Grandson of Wallis
Simpson (Bessie Wallis Warfield-Spencer-Simpson) USA wife of
Edward VIII & King of UK Edward VIII “David” (Edward Albert
Christian George Andrew Patrick David) Prince of Wales UK, Duke
& Duchess of Windsor .
In other words, Dr. Mark Babizhayev has an "Unofficial Status of a
King of UK" and is the Major relative of the British Royal Family.
If we would not hear the positive answer from your Staff at soonest,
being appropriate, we will raise the Public Discussion against your
Journal through the Washington Post and other important International
platforms through Twitter, accordingly.
Please, review the Twitter account of our Group :
https://twitter.com/markinmonaco/with_replies
Note, that the materials of the submission have been patented by the
Author according to the PCT system.
After we manage to start and act against your Staff in the mentioned
above way, if you fail to comply with our Requirements of publication,
11. 11
we predict that your Journal would be most probably removed from the
Public Domain based on the importance of the considered issues.
You will not gain from your rejection, neither you will be able to save
space in your Journal dedicated to another (more "preferable")
submissions.
We are very interested to hear your next comments.
Thank you.
Cordially, Dr. Mark Babizhayev
--------------------------------------------
On Thu, 8/18/16, Macromolecular Bioscience
<em@editorialmanager.com> wrote:
Subject: Your submission to Macromolecular Bioscience
(mabi.201600354) - [EMID:ede5826a460a4a62]
To: "Mark Babizhayev" <markbabizhayev2005@yahoo.com>
Date: Thursday, August 18, 2016, 4:17 PM
Dear Dr. Babizhayev,
Thank you for submitting your manuscript "Advanced Glycation
End Products : Regulation, Function and Role in Health and
Disease. Free Radical Generation by Early Glycation Products
as a Mechanism for Long-Term Complications of Diabetes
Mellitus" (mabi.201600354) to Macromolecular Bioscience.
Unfortunately, we are not able to consider it further for
publication.
As we receive many more manuscripts than we can possibly
publish, or even send out for review, we are forced to adopt
a stringent selection process. We therefore can only select
those manuscripts we believe will interest the broadest
possible section of our readership and represent a
significant breakthrough of general interest.
12. 12
We therefore did not want to delay this decision and wish
you success in submission of the manuscript to another
journal.
Thank you for considering Macromolecular Bioscience.
Yours sincerely,
David Huesmann
-----
Dr. David Huesmann, Editor
Macromolecular Bioscience
Email: macromol@wiley-vch.de
Phone: +49 6201-606-581
http://mbs-journal.de/
*****
Have you seen our new interdisciplinary premium open access
journal Advanced Science? For more information or to submit
now go to www.advancedscience.com
*****
Wiley-VCH Verlag GmbH & Co. KGaA – A company of John
Wiley & Sons, Inc. - Location of the Company: Weinheim -
Trade Register: Mannheim, HRB 432833.
Chairman of the Supervisory Board: Mark Allin. General
Partner: John Wiley & Sons GmbH, Location: Weinheim –
Trade Register Mannheim, HRB 432296 – Managing Directors:
Sabine Steinbach, Philip Carpenter
*****
*****
***
13. 13
Declaration on Patenting, Originality and Linguistics
Dear Editors ,
Dear Sir/Madam ,
Please, consider below our Declaration of Interest/Explanation :
The main concern of the originality raised during the application and uses
CrossCheck powered by iThenticate software is the subject of plagiarism.
This programme is dedicated to reveal the subjects of plagiarism in the
submitted manuscripts.
The application of iThenticate programme to the current case is prohibited as
there is no traces of plagiarism in the contents of this article supported by the
filed and issued Patents according to the PCT International system cited
below.
See below the more detailed description of the case.
The Journal employs a plagiarism detection system. By submitting the
manuscript to the Journal one accepts that the submitted manuscript may be
screened for plagiarism. However, kindly note that this subject of originality
is not sufficient and is not legally applicable to the current submitted article
and to this considered case.
The reason of this is as follows :
The clue moment of the raised dispute with your Journal is the point about
plagiarism. If it is officially clear that there are NO traces of plagiarism in the
submitted article that is supported by the presented and clearly cited in the
scope of the Manuscript PCT patent applications which privilege the priority
of the Authors in this field and the absence of the prior art/published issues
infringing the priority of the Authors, accordingly there are absolutely NO
other intent or restrictions to make the wording text new or original
according to your criteria based on the use iThenticate software .
The therapeutic modalities described in details in the text and the content of
the current submission have been specifically patented by the Author (Dr.
Mark A. Babizhayev) with the list of the International PCT patent
applications worldwide available and US Patents allowed and pending :
WO 94/19325;
14. 14
WO 95/12581;
WO 2004/064866 A1
Babizhayev, M.A. and Meguro, K., 2004. COMBINED USE OF
CARNOSINASE INHIBITOR WITH L-CARNOSINES AND
COMPOSITION. WO 2004/064866 PCT/JP2004/000351. Filed 20 January
2003 (20.01.2003).
The Patent Applications and allowed Patents are listed in the scope of the
submitted manuscript of the article.
Thus, according to the PCT convention and the acting International rules, this
work can NOT be considered as plagiarism or self-plagiarism of any kind
because all States allocated charges and fees have been timely and accurately
payed by Dr. Babizhayev and the priority validity of the Inventions and the
contents of the material to the name of Dr. Mark A. Babizhayev and disclosed
in this submission has been proved in front of the US Patent Office , European
Patent Office and the Japanese Patent Office thus appearing quite original
through the World.
The present submission of the considered article summarizes the contents of
the patented Inventions, Claims and its Specifications which might be
remained unchanged in their contents with the major parts .
Please, appreciate that according the existing rules of the PCT Convention of
Intellectual Property, after filing the PCT applications supporting the priority
of the Applicant, the Authors can use any kind of the published material to
promote scientifically and industrially this kind of patented Intellectual
property, making the due citations where necessary. Obviously, the references
to all necessary materials have been duly made punctially in the scope of the
considered article. The percentage of repetitions is significantly low,
according to your Report.
Accordingly , we suggest in compliance with the acting International law, that
based on the available International patent protection, we can insist that your
reputable Journal can process our submitted work for the review/publication
without making revisions as presented by Reviewer for linguistic repetitions
in some places of the article as it is obvious that there is no sign of plagiarism
in the presented work describing the patented therapeutic modality.
As there are factually NO TRACES OF ANY TYPE OF PLAGIARISM in the
submitted Manuscript, there are no other reasons to insist on the completely
15. 15
different wording in the text of the article , in view that all due citations in the
submitted article have been accurately made. The linguistic phonema used
might be legally preserved in several parts of the article for clarity on the
distinguished desire of the Authors.
Truly, the manuscript overall represents quite original material in its
proprietary and other senses with no component of plagiarism existing.
It is anticipated that you might be willing to legally traverse the reasons of
decline/rejection of our manuscript, if any.
The similarities can not be judged as an objective or subjective reason of
rejection per se. The linguistic similarities per se are occurred everywhere,
Any sentence includes the words that are repeated from time to time, the
words in English language contain the similar set of the chosen letters in Latin
that are repeated regularly in many sentences through the text as a matter of
fact. The linguistic similarities per se can not be the reason of rejections.
Now , it is clear to you that there are no traces of plagiarism in our
submission, and as such, we have the authorized right to use any information
we want to prove our ideas with clarity, supported by the PCT Convention of
Intellectual property, we have presented the numbers of the available Patents
and International Patent Applications in our possession in the current
submission.
Your Journal belongs to the International reputable Publishing Scientific
House , which Organization should respect the International Laws of
Intellectual Properties.
Thank you.
Kindly, note that there is no personal prejudice or the unrespected attitude to
your Journal or Publishers in the above stated disclosure.
Thank you very much for your pending amicable and Intellectual
consideration of the Problem.
Looking forward to hearing from you with the weighted response and
pending acceptance of our official position.
Thank you.
Cordially, Dr. Mark A. Babizhayev, Ph.D., Executive Director, Innovative
16. 16
Vision Products, Inc., DE, USA.
Innovative Vision Products, Inc.
Delaware Office :
3511 Silverside Road, Suite 105, County of New Castle, Delaware, USA 19810
e-mail: markbabizhayev@yahoo.com
Moscow Office :
Ivanovskaya 20, Suite 74,
Moscow 127434, Russian Federation
e-mail: markbabizhayev@mail.ru
Tel/Fax: +7(499)977-2387
mobile phone : +7(965)371-79-89
Skype address: Dr_Mark_Babizhayev
http://www.innovative-vision-products.com